Clinical characteristics and outcomes of critically ill mechanically ventilated COVID-19 patients receiving interleukin-6 receptor antagonists and corticosteroid therapy: a preliminary report from a multinational registry

10Citations
Citations of this article
155Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Background: Interleukin-6 receptor antagonists (IL-6RAs) and steroids are emerging immunomodulatory therapies for severe and critical coronavirus disease (COVID-19). In this preliminary report, we aim to describe the epidemiology, clinical characteristics, and outcomes of adult critically ill COVID-19 patients, requiring invasive mechanical ventilation (iMV), and receiving IL-6RA and steroids therapy over the last 11 months. Materials and methods: International, multicenter, cohort study derived from Viral Infection and Respiratory Illness University Study registry and conducted through Discovery Network, Society of Critical Care Medicine. Data were collected between March 01, 2020, and January 10, 2021. Results: Of 860 patients who met eligibility criteria, 589 received steroids, 170 IL-6RAs, and 101 combinations. Patients who received IL-6RAs were younger (median age of 57.5 years vs. 61.1 and 61.8 years in the steroids and combination groups, respectively). The median C-reactive protein level was > 75 mg/L, indicating a hyperinflammatory phenotype. The median daily steroid dose was 7.5 mg dexamethasone or equivalent (interquartile range: 6–14 mg); 80.8% and 19.2% received low-dose and high-dose steroids, respectively. Of the patients who received IL-6RAs, the majority received one dose of tocilizumab and sarilumab (dose range of 600–800 mg for tocilizumab and 200–400 mg for sarilumab). Regarding the timing of administration, we observed that steroid and IL-6RA administration on day 0 of ICU admission was only 55.6% and 39.5%, respectively. By day 28, when compared with steroid use alone, IL-6RA use was associated with an adjusted incidence rate ratio (aIRR) of 1.12 (95% confidence interval [CI] 0.88, 1.4) for ventilator-free days, while combination therapy was associated with an aIRR of 0.83 (95% CI 0.6, 1.14). IL-6RA use was associated with an adjusted odds ratio (aOR) of 0.68 (95% CI 0.44, 1.07) for the 28-day mortality rate, while combination therapy was associated with an aOR of 1.07 (95% CI 0.67, 1.70). Liver dysfunction was higher in IL-6RA group (p = 0.04), while the bacteremia rate did not differ among groups. Conclusions: Discordance was observed between the registry utilization patterns (i.e., timing of steroids and IL-6RA administration) and new evidence from the recent randomized controlled trials and guideline recommendations. These data will help us to identify areas of improvement in prescribing patterns and enhance our understanding of IL-6RA safety with different steroid regimens. Further studies are needed to evaluate the drivers of hospital-level variation and their impact on clinical outcomes. Trial registration ClinicalTrials.gov: NCT04486521. Registered on July 2020.

References Powered by Scopus

ROBINS-I: A tool for assessing risk of bias in non-randomised studies of interventions

11632Citations
N/AReaders
Get full text

Dexamethasone in hospitalized patients with covid-19

7690Citations
N/AReaders
Get full text

The strengthening the reporting of observational studies in epidemiology (STROBE) statement: Guidelines for reporting observational studies

6898Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Antimicrobial resistance in patients with COVID-19: a systematic review and meta-analysis

96Citations
N/AReaders
Get full text

Targeting the Complement–Sphingolipid System in COVID-19 and Gaucher Diseases: Evidence for a New Treatment Strategy

10Citations
N/AReaders
Get full text

Factors that influence mortality in critically ill patients with sars-cov-2 infection: A multicenter study in the kingdom of saudi arabia

9Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Amer, M., Kamel, A. M., Bawazeer, M., Maghrabi, K., Butt, A., Dahhan, T., … Kashyap, R. (2021). Clinical characteristics and outcomes of critically ill mechanically ventilated COVID-19 patients receiving interleukin-6 receptor antagonists and corticosteroid therapy: a preliminary report from a multinational registry. European Journal of Medical Research, 26(1). https://doi.org/10.1186/s40001-021-00591-x

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 23

57%

Researcher 9

23%

Lecturer / Post doc 5

13%

Professor / Associate Prof. 3

8%

Readers' Discipline

Tooltip

Medicine and Dentistry 27

61%

Nursing and Health Professions 7

16%

Pharmacology, Toxicology and Pharmaceut... 6

14%

Engineering 4

9%

Article Metrics

Tooltip
Social Media
Shares, Likes & Comments: 12

Save time finding and organizing research with Mendeley

Sign up for free